140 related articles for article (PubMed ID: 16699268)
1. Drugs affecting visceral sensitivity: ready for the prime time?
Delvaux MM; Gay G
Dig Dis; 2006; 24(1-2):99-104. PubMed ID: 16699268
[TBL] [Abstract][Full Text] [Related]
2. Visceral hypersensitivity in functional disorders of the upper gastrointestinal tract.
Sarnelli G; Vandenberghe J; Tack J
Dig Liver Dis; 2004 Jun; 36(6):371-6. PubMed ID: 15248374
[TBL] [Abstract][Full Text] [Related]
3. Somatic referral of visceral sensations and rectal sensory threshold for pain in children with functional gastrointestinal disorders.
Faure C; Wieckowska A
J Pediatr; 2007 Jan; 150(1):66-71. PubMed ID: 17188617
[TBL] [Abstract][Full Text] [Related]
4. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.
Bueno L; de Ponti F; Fried M; Kullak-Ublick GA; Kwiatek MA; Pohl D; Quigley EM; Tack J; Talley NJ
Neurogastroenterol Motil; 2007 Jan; 19(1 Suppl):89-119. PubMed ID: 17280587
[TBL] [Abstract][Full Text] [Related]
5. Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders--the clinical evidence.
Kuiken SD; Tytgat GN; Boeckxstaens GE
Aliment Pharmacol Ther; 2005 Mar; 21(6):633-51. PubMed ID: 15771750
[TBL] [Abstract][Full Text] [Related]
6. Visceral sensitivity perturbation integration in the brain-gut axis in functional digestive disorders.
Bonaz B
J Physiol Pharmacol; 2003 Dec; 54 Suppl 4():27-42. PubMed ID: 15075447
[TBL] [Abstract][Full Text] [Related]
7. [Progress in role of estrogens in visceral hypersensitivity of IBS].
Dong X; Chen SL
Sheng Li Ke Xue Jin Zhan; 2010 Oct; 41(5):362-4. PubMed ID: 21416927
[No Abstract] [Full Text] [Related]
8. Abnormal forebrain activity in functional bowel disorder patients with chronic pain.
Kwan CL; Diamant NE; Pope G; Mikula K; Mikulis DJ; Davis KD
Neurology; 2005 Oct; 65(8):1268-77. PubMed ID: 16247056
[TBL] [Abstract][Full Text] [Related]
9. [Visceral sensitivity disturbances in the pathogenesis of functional gastrointestinal disorders].
Mazur M; Furgała A; Thor PJ
Folia Med Cracov; 2004; 45(1-2):33-49. PubMed ID: 16276824
[TBL] [Abstract][Full Text] [Related]
10. The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients.
Klooker TK; Leliefeld KE; Van Den Wijngaard RM; Boeckxstaens GE
Neurogastroenterol Motil; 2011 Jan; 23(1):30-5, e2. PubMed ID: 20718944
[TBL] [Abstract][Full Text] [Related]
11. Visceral perception in functional gastro-intestinal disorders: disease marker or epiphenomenon?
Hu WH; Talley NJ
Dig Dis; 1996; 14(5):276-88. PubMed ID: 8902414
[TBL] [Abstract][Full Text] [Related]
12. 5-HT receptors and visceral hypersensitivity - 2B or not 2B, that is the question?
Grundy D
Neurogastroenterol Motil; 2006 May; 18(5):339-42. PubMed ID: 16629859
[No Abstract] [Full Text] [Related]
13. Involvement of cannabinoid receptors in gut motility and visceral perception.
Hornby PJ; Prouty SM
Br J Pharmacol; 2004 Apr; 141(8):1335-45. PubMed ID: 15100166
[TBL] [Abstract][Full Text] [Related]
14. Amitriptyline modifies the visceral hypersensitivity response to acute stress in the irritable bowel syndrome.
Thoua NM; Murray CD; Winchester WJ; Roy AJ; Pitcher MC; Kamm MA; Emmanuel AV
Aliment Pharmacol Ther; 2009 Mar; 29(5):552-60. PubMed ID: 19076934
[TBL] [Abstract][Full Text] [Related]
15. Visceral sensitivity testing.
Andresen V
Best Pract Res Clin Gastroenterol; 2009; 23(3):313-24. PubMed ID: 19505661
[TBL] [Abstract][Full Text] [Related]
16. Is visceral hypersensitivity correlated with symptom severity in children with functional gastrointestinal disorders?
Castilloux J; Noble A; Faure C
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):272-8. PubMed ID: 18376243
[TBL] [Abstract][Full Text] [Related]
17. In vivo and transgenic animal models used to study visceral hypersensitivity.
Fioramonti J; Gebhart GF
Neurogastroenterol Motil; 2007 Jan; 19(1 Suppl):20-8. PubMed ID: 17280583
[TBL] [Abstract][Full Text] [Related]
18. Testing of visceral sensitivity.
Mulak A
J Physiol Pharmacol; 2003 Dec; 54 Suppl 4():55-72. PubMed ID: 15075449
[TBL] [Abstract][Full Text] [Related]
19. Central sensitisation in visceral pain disorders.
Moshiree B; Zhou Q; Price DD; Verne GN
Gut; 2006 Jul; 55(7):905-8. PubMed ID: 16766744
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiology and clinical phenomenology of visceral pain].
Gschossmann JM; Holtmann G; Mayer EA
Schmerz; 2002 Dec; 16(6):447-51. PubMed ID: 12474030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
